Differences in disease phenotype and severity in SLE across age groups

por Ambrose, N, Morgan, T A, Galloway, J, Ionnoau, Y, Beresford, M W, Isenberg, D A
Publicado 2016

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children

por Ramos-Martín, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., Paulus, S., López-Herce, J., Hope, W. W.
Publicado 2017

Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis

por Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., Gardner-Medwin, J., Beresford, M. W., Symmons, D., Thomson, W., Elliott, R. A.
Publicado 2008

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for child...

por Ramanan, A. V., Hampson, L. V., Lythgoe, H, Jones, A. P., Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N, Davidson, J, Ferguson, P. J., Herlin, T, Kavirayani, A, Killeen, O. G., Compeyrot-Lacassagne, S, Laxer, R. M., Roderick, M, Swart, J. F., Hedrich, C. M., Beresford, M. W.
Publicado 2019

Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups

por Massias, J S, Smith, E M D, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, D P, Leahy, A, Leone, V, McErlane, F, Mewar, D, Modgil, G, Moots, R, Pilkington, C, Ramanan, A V, Rangaraj, S, Riley, P, Sridhar, A, Wilkinson, N, Beresford, M W, Hedrich, C M
Publicado 2020